CHRNA7 Polymorphisms and Response to Cholinesterase Inhibitors in Alzheimer's Disease

PLoS ONE - United States
doi 10.1371/journal.pone.0084059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Use of Cholinesterase Inhibitors Increases Initiation of Urinary Anticholinergics in Persons With Alzheimer's Disease

Journal of the American Geriatrics Society
GerontologyGeriatrics
2016English

Review: Cholinesterase Inhibitors Have a Modest Effect on Neuropsychiatric and Functional Outcomes in Alzheimer's Disease

Evidence-Based Mental Health
PsychiatryMental Health
2003English

Peripheral Vascular Responses to Acetylcholine as a Predictive Tool for Response to Cholinesterase Inhibitors in Alzheimer’s Disease

BMC Neurology
MedicineNeurology
2019English

Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer's Disease

Journal of Managed Care Pharmacy
2008English

1369 Is Plasma Cholinesterase a Reliable Biomarker in Long-Term Exposure to Cholinesterase Inhibitors?

2018English

Genetic Association Between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2011English

Elucidating the Mechanisms Underlying Alzheimer's Disease-Associated Genetic Polymorphisms

Molecular Neurodegeneration
Molecular NeuroscienceNeurologyMolecular BiologyCellular
2012English

Use of Cholinesterase Inhibitors in Dementia

Advances in Psychiatric Treatment
2002English

Screening and Analysis of Acetyl-Cholinesterase (AChE) Inhibitors in the Context of Alzheimer’s Disease

Bioinformation
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy